Abstract

There is insufficient evidence regarding safety and benefits of lipid-lowing drugs in individuals ≥ 75 years old. As the population ages, cardiovascular disease and major adverse coronary events became more prevalent. This is a quick review of the most important and latest studies concerning the use of statins in primary and secondary prevention in elderly. Population aging brings the discussion about benefit of cardiovascular preventive measures in elderly specially in primary prevention setting. Previous studies showed a direct relationship between blood cholesterol levels and ischemic heart disease mortality [1]. However, age seems to substantially attenuate the proportional relation of CVD with cholesterol, suggesting that the impact of blood cholesterol treatment in reducing CVD events could be lower in elderly subjects. In this brief review we discuss some aspects of lipid lowering in older population